Post Pacemaker & ICD Infection Readmissions at Top Hospitals continue to pose challenges

In Cardiovascular

Get Dexur’s Personalized Hospital Specific Presentation on Quality, Safety, Compliance & Education

By: Avinash Kumar May. 30, 2019

Infections developed from cardiovascular implantable electronic devices (CIED) implant procedures are serious complications and lead to follow on readmissions. Dexur Analysed Medicare Inpatient data for the year Jan 2017 to Dec 2017, to determine post - CIED infections related readmission. Below is a table of five large top 5 Hospitals performing CIED procedures and post CIED infection readmission rates at 30 days and 1 year.

HOSPITAL NAME	30 Day Post CIED Infection Readmission Rates	1 Year Post CIED Infection Readmission Rates
NATIONAL	2.01	4.82
ST. FRANCIS HOSPITAL, ROSLYN, NEW YORK	1.87	4.24
MOUNT SINAI HOSPITAL, NEW YORK, NEW YORK	2.47	6.82
NASSAU HEALTH CARE CORP, EAST MEADOW, NEW YORK	3	5.12
ALLINA HEALTH SYSTEM, MINNEAPOLIS, MINNESOTA	1.1	3.86
CENTRAL VERMONT MEDICAL CENTER INC, BERLIN, VERMONT	2.46	8.1

The National average for Post CIED infection readmission rates are at 2.01% for 30 day and 4.82% for 1 year. Of the top 5 hospitals, Allina Health System of Minneapolis, Minnesota had the lowest 30 day (1.1%) and 1 year (3.86%) infection readmission rates followed by St. Francis Hospital of Roslyn, New York with 30 day at 1.87% and 1 year at 4.24%. These readmission rates with infection are less than the US average.

Central Vermont Medical Center of Berlin, Vermont’s 30 day (2.46%) and 1 year (8.1%), Mount Sinai Hospital of New York’s 30 day (2.47%) and 1 year (6.82%), and Nassau Health Care of East Meadow, New York’s 30 day (3%) and 1 year (5.12%) had readmission rates higher than the National average.

Central Vermont Medical Center’s 1 year post CIED infection readmission rate is almost double the national average.

DEXUR PRO MEMBERS:

SIGN UP NOW TO ACCESS ADDITIONAL RESEARCH FOR THIS ARTICLE

Dexur Pro members get detailed quality outcomes of CIED implantation procedures

Cost and payments related to post CIED Infection readmissions
All cause readmission rates - 30 days,90 days, 1 year
Infection readmission rates - 30 days,90 days, 1 year
Bleed readmission rates - 30 days,90 days, 1 year
Pericardial Effusion readmission rates - 30 days,90 days, 1 year
Pleural Effusion readmission rates - 30 days,90 days, 1 year
Replacement readmission rates - 30 days,90 days, 1 year
Revision readmission rates - 30 days,90 days, 1 year
All cause readmission discharges - 30 days,90 days, 1 year
Infection readmission discharges - 30 days,90 days, 1 year
Bleed readmission discharges - 30 days,90 days, 1 year
Pericardial Effusion readmission discharges - 30 days,90 days, 1 year
Pleural Effusion readmission discharges - 30 days,90 days, 1 year
Replacement readmission discharges - 30 days,90 days, 1 year
Revision readmission discharges - 30 days,90 days, 1 year
Top 5 DRG category discharges

ABOUT THE AUTHOR

Avinash Kumar

Avinash Kumar is a Business analyst with over 9 years of healthcare experience. He has expertise in Real World Evidence (RWE), healthcare claims analytics, market research, data analytics, benefits configuration, claim contractual reprising, adjudication, implementation of reimbursement rule edits for healthcare payers and revenue cycle management for providers. Avinash holds a Master's degree in Operations management and life sciences. He is a certified medical coder from American Association of Professional Coders (AAPC).